RxSight, Inc. (RXST) Dividend History

RxSight, Inc. is a medical device company specializing in the development and commercialization of innovative ophthalmic products. Its primary focus is on improving outcomes for patients undergoing cataract surgery through its flagship product, the Light Adjustable Lens (LAL), which allows customization and post-operative adjustments to optimize visual results. The company’s technology aims to enhance the precision and flexibility of cataract treatment.

100 Columbia Street, Aliso Viejo, CA, 92656
Phone: 949-521-7822
Website: https://www.rxsight.com

Dividend History

RxSight, Inc. currently does not pay dividends

Company News

RxSight Warns On FY25 Revenue As Premium Cataract Market Faces Headwinds, Stock Plunges

RxSight reported Q1 revenue up 28% YoY but below consensus, and lowered its FY25 revenue outlook due to headwinds in the premium cataract market.

Benzinga
RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Financial and Operational Results and 2025 Guidance

RxSight, Inc. reported strong preliminary unaudited financial and operational results for Q4 2024 and provided guidance for 2025, indicating continued growth in the adoption of its Light Adjustable Lens system.

GlobeNewswire Inc.
RxSight, Inc. to Report Second Quarter Financial Results on August 5, 2024 - GlobeNewswire

RxSight, Inc., an ophthalmic medical device company, announced that it will report its financial results for the second quarter of 2024 on August 5, 2024. The company will host a conference call to discuss the results.

GlobeNewswire Inc.
RxSight, Inc. To Participate in the Truist Securities Medtech Conference

ALISO VIEJO, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming Truist Securities MedTech Conference.

GlobeNewswire Inc.
What Makes RxSight, Inc. (RXST) a Strong Momentum Stock: Buy Now?

Does RxSight, Inc. (RXST) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks Investment Research

Dividend data last updated 06/07/2025 04:55:27 UTC